COVID-19 Updates

Company and industry updates related to the COVID-19 outbreak

COVID-19 Updates

Company and industry updates related to the COVID-19 outbreak

COVID-19 Updates

Company and industry updates related to the COVID-19 outbreak

COVID-19 Updates

Company and industry updates related to the COVID-19 outbreak

COVID-19 Updates

Company and industry updates related to the COVID-19 outbreak

COVID-19 Updates

Both the Canadian and American federal governments have recognized and reinforced the importance of continuing with the unimpeded flow of goods between our two countries. This means the Canada/U.S. border remains open for international trade. We will continue to monitor the events affecting trade, and will provide updates to our website should conditions change.

J.B. Ellis takes the health and safety of our employees seriously. Our team, like countless others, is closely monitoring the latest updates on the COVID-19 outbreak. We are taking additional measures to ensure we safeguard the health of our employees, while continuing to provide the high level of service you have come to expect. Following the recommendations of the World Health Organization, we have implemented a work from home program, which not only allows us to meet the service demands, but does so in accordance with our newly developed safety protocols. We would like to thank everyone for their patience and understanding.

Let’s all do our best to stay safe as we navigate through these extraordinary times.

COVID-19 Updates

Both the Canadian and American federal governments have recognized and reinforced the importance of continuing with the unimpeded flow of goods between our two countries. This means the Canada/U.S. border remains open for international trade. We will continue to monitor the events affecting trade, and will provide updates to our website should conditions change.

J.B. Ellis takes the health and safety of our employees seriously. Our team, like countless others, is closely monitoring the latest updates on the COVID-19 outbreak. We are taking additional measures to ensure we safeguard the health of our employees, while continuing to provide the high level of service you have come to expect. Following the recommendations of the World Health Organization, we have implemented a work from home program, which not only allows us to meet the service demands, but does so in accordance with our newly developed safety protocols. We would like to thank everyone for their patience and understanding.

Let’s all do our best to stay safe as we navigate through these extraordinary times.

COVID-19 CBSA Customs Notices:

CN20-19 Certain Goods Remission Order (COVID-19) *Repealed as of May 7, 2022 - see CN22-08*- This Customs Notice provides information on the Certain Goods Remission Order (COVID-19), SOR-2020-101, which allows for the relief of customs duty for eligible goods which were imported on or after May 5, 2020. This relief can be claimed at the time of importation or within two years of the date of importation.

To see all goods that qualify under this new Remission Order, please visit https://www.cbsa-asfc.gc.ca/publications/cn-ad/cn20-19-eng.html

CN20-12 Tariff Classification and Other Information to Import Medical Supplies (COVID-19)- The purpose of this Customs Notice is to help inform the commercial importing community of the tariff classification number and other potentially useful information for the importation of certain medical supplies.

CN20-08 Imported Goods for Emergency Use in Response to COVID-19 *Expired as of May 7, 2022 - see CN22-09*This Customs Notice provides information on the use of the Goods for Emergency Use Remission Order and application of Tariff Item No. 9993.00.00 of the Customs Tariff in response to the COVID-19 pandemic.

CN20-36 Importation of COVID-19 Vaccines and Drugs- The purpose of this Customs Notice is to provide importers and carriers with guidance on importing COVID-19 drugs, including vaccines, covered under Health Canada’s Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19.

 

COVID-19 CBSA Customs Notices:

CN20-19 Certain Goods Remission Order (COVID-19)- This Customs Notice provides information on the Certain Goods Remission Order (COVID-19), SOR-2020-101, which allows for the relief of customs duty for eligible goods which were imported on or after May 5, 2020. This relief can be claimed at the time of importation or within two years of the date of importation.

To see all goods that qualify under this new Remission Order, please visit https://www.cbsa-asfc.gc.ca/publications/cn-ad/cn20-19-eng.html

CN20-12 Tariff Classification and Other Information to Import Medical Supplies (COVID-19)- The purpose of this Customs Notice is to help inform the commercial importing community of the tariff classification number and other potentially useful information for the importation of certain medical supplies.

CN20-08 Imported Goods for Emergency Use in Response to COVID-19- This Customs Notice provides information on the use of the Goods for Emergency Use Remission Order and application of Tariff Item No. 9993.00.00 of the Customs Tariff in response to the COVID-19 pandemic.

CN20-36 Importation of COVID-19 Vaccines and Drugs- The purpose of this Customs Notice is to provide importers and carriers with guidance on importing COVID-19 drugs, including vaccines, covered under Health Canada’s Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19.

 

JB ELLIS FOOTER-1

© J.B. Ellis & Co. Ltd. All rights are reserved